Ahmed Zaki  Sabet net worth and biography

Ahmed Sabet Biography and Net Worth

COO of Precipio
A. Zaki Sabet has been with Precipio since co-founding the company in 2011 and currently serves as the Chief Operating Officer. He holds over 12 years of experience in laboratory management spanning all fields of reference laboratory operations primarily focusing on cancer diagnostics. Prior to Precipio, Zaki has served as a consultant with the College of American Pathologists (CAP) for many years as well as several diagnostic companies in setting up their specialized cancer testing operations. Zaki holds a Bachelor of Science degree in Biomedical Engineering from the New Jersey Institute of Technology.

What is Ahmed Zaki Sabet's net worth?

The estimated net worth of Ahmed Zaki Sabet is at least $1,979.11 as of January 3rd, 2023. Mr. Sabet owns 343 shares of Precipio stock worth more than $1,979 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Sabet may own. Additionally, Mr. Sabet receives an annual salary of $229,030.00 as COO at Precipio. Learn More about Ahmed Zaki Sabet's net worth.

How old is Ahmed Zaki Sabet?

Mr. Sabet is currently 37 years old. There are 3 older executives and no younger executives at Precipio. The oldest executive at Precipio is Mr. Matthew Gage, Chief Financial Officer, who is 57 years old. Learn More on Ahmed Zaki Sabet's age.

What is Ahmed Zaki Sabet's salary?

As the COO of Precipio, Inc., Mr. Sabet earns $229,030.00 per year. There are 2 executives that earn more than Mr. Sabet. The highest earning executive at Precipio is Mr. Ilan Danieli, Founder, President, CEO & Director, who commands a salary of $324,100.00 per year. Learn More on Ahmed Zaki Sabet's salary.

How do I contact Ahmed Zaki Sabet?

The corporate mailing address for Mr. Sabet and other Precipio executives is 4 Science Park, New Haven CT, 06511. Precipio can also be reached via phone at (203) 787-7888 and via email at [email protected]. Learn More on Ahmed Zaki Sabet's contact information.

Has Ahmed Zaki Sabet been buying or selling shares of Precipio?

Ahmed Zaki Sabet has not been actively trading shares of Precipio over the course of the past ninety days. Most recently, on Tuesday, January 3rd, Ahmed Zaki Sabet bought 37 shares of Precipio stock. The stock was acquired at an average cost of $12.00 per share, with a total value of $444.00. Following the completion of the transaction, the chief operating officer now directly owns 343 shares of the company's stock, valued at $4,116. Learn More on Ahmed Zaki Sabet's trading history.

Who are Precipio's active insiders?

Precipio's insider roster includes David Cohen (Director), Ilan Danieli (CEO), and Ahmed Sabet (COO). Learn More on Precipio's active insiders.

Ahmed Zaki Sabet Insider Trading History at Precipio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2023Buy37$12.00$444.00343View SEC Filing Icon  
10/3/2022Buy25$17.40$435.00305View SEC Filing Icon  
3/1/2022Buy16$30.80$492.80View SEC Filing Icon  
12/1/2021Buy12$37.80$453.60View SEC Filing Icon  
9/7/2021Buy7$67.00$469.00View SEC Filing Icon  
6/1/2021Buy7$67.40$471.80243View SEC Filing Icon  
12/1/2020Buy11$44.60$490.60236View SEC Filing Icon  
9/1/2020Buy6$43.20$259.20225View SEC Filing Icon  
7/7/2020Buy8$32.00$256.00218View SEC Filing Icon  
See Full Table

Ahmed Zaki Sabet Buying and Selling Activity at Precipio

This chart shows Ahmed Zaki Sabet's buying and selling at Precipio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Precipio Company Overview

Precipio logo
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
Read More

Today's Range

Now: $5.77
Low: $5.71
High: $5.77

50 Day Range

MA: $6.38
Low: $5.86
High: $6.84

2 Week Range

Now: $5.77
Low: $4.75
High: $14.80

Volume

1,737 shs

Average Volume

6,198 shs

Market Capitalization

$8.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61